To Determine Long Term Efficacy and Safety of Asenapine in Schizophrenic Patient Population (A7501012)(COMPLETED)(P05770)

NCT00150176 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

831

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Asenapine - Open Label
DRUG: Placebo - Double Blind
DRUG: Asenapine - Double Blind

Sponsor

Organon and Co